These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Levi H; Carmi S; Rosset S; Yerushalmi R; Zick A; Yablonski-Peretz T; ; Wang Q; Bolla MK; Dennis J; Michailidou K; Lush M; Ahearn T; Andrulis IL; Anton-Culver H; Antoniou AC; Arndt V; Augustinsson A; Auvinen P; Beane Freeman L; Beckmann M; Behrens S; Bermisheva M; Bodelon C; Bogdanova NV; Bojesen SE; Brenner H; Byers H; Camp N; Castelao J; Chang-Claude J; Chirlaque MD; Chung W; Clarke C; ; Collee MJ; Colonna S; ; Couch F; Cox A; Cross SS; Czene K; Daly M; Devilee P; Dork T; Dossus L; Eccles DM; Eliassen AH; Eriksson M; Evans G; Fasching P; Fletcher O; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; García-Closas M; Garcia-Saenz JA; Genkinger J; Giles GG; Goldberg M; Guénel P; Hall P; Hamann U; He W; Hillemanns P; Hollestelle A; Hoppe R; Hopper J; ; Jakovchevska S; Jakubowska A; Jernström H; John E; Johnson N; Jones M; Vijai J; Kaaks R; Khusnutdinova E; Kitahara C; Koutros S; Kristensen V; Kurian AW; Lacey J; Lambrechts D; Le Marchand L; Lejbkowicz F; Lindblom A; Loibl S; Lori A; Lubinski J; Mannermaa A; Manoochehri M; Mavroudis D; Menon U; Mulligan A; Murphy R; Nevelsteen I; Newman WG; Obi N; O'Brien K; Offit K; Olshan A; Plaseska-Karanfilska D; Olson J; Panico S; Park-Simon TW; Patel A; Peterlongo P; Rack B; Radice P; Rennert G; Rhenius V; Romero A; Saloustros E; Sandler D; Schmidt MK; Schwentner L; Shah M; Sharma P; Simard J; Southey M; Stone J; Tapper WJ; Taylor J; Teras L; Toland AE; Troester M; Truong T; van der Kolk LE; Weinberg C; Wendt C; Yang XR; Zheng W; Ziogas A; Dunning AM; Pharoah P; Easton DF; Ben-Sachar S; Elefant N; Shamir R; Elkon R J Med Genet; 2023 Nov; 60(12):1186-1197. PubMed ID: 37451831 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376175 [TBL] [Abstract][Full Text] [Related]
26. Risk factors for breast cancer from benign breast disease in a diverse population. Worsham MJ; Raju U; Lu M; Kapke A; Botttrell A; Cheng J; Shah V; Savera A; Wolman SR Breast Cancer Res Treat; 2009 Nov; 118(1):1-7. PubMed ID: 18836828 [TBL] [Abstract][Full Text] [Related]
27. The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. Zhou WB; Xue DQ; Liu XA; Ding Q; Wang S J Cancer Res Clin Oncol; 2011 Jul; 137(7):1053-60. PubMed ID: 21499874 [TBL] [Abstract][Full Text] [Related]
28. Model for individualized prediction of breast cancer risk after a benign breast biopsy. Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442 [TBL] [Abstract][Full Text] [Related]
29. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777 [TBL] [Abstract][Full Text] [Related]
30. The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer: a prospective study. Keyzer-Dekker CM; de Vries J; Mertens MC; Roukema JA; van der Steeg AF Br J Health Psychol; 2014 Nov; 19(4):783-94. PubMed ID: 25295696 [TBL] [Abstract][Full Text] [Related]
31. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Giustarini E; Pinchera A; Fierabracci P; Roncella M; Fustaino L; Mammoli C; Giani C Eur J Endocrinol; 2006 May; 154(5):645-9. PubMed ID: 16645010 [TBL] [Abstract][Full Text] [Related]
32. Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk prediction. Hovhannisyan M; Zemankova P; Nehasil P; Matejkova K; Borecka M; Cerna M; Dolezalova T; Dvorakova L; Foretova L; Horackova K; Jelinkova S; Just P; Kalousova M; Kral J; Machackova E; Nemcova B; Safarikova M; Springer D; Stastna B; Tavandzis S; Vocka M; Zima T; Soukupova J; Kleiblova P; Ernst C; Kleibl Z; Janatova M Cancer; 2024 Sep; 130(17):2978-2987. PubMed ID: 38718029 [TBL] [Abstract][Full Text] [Related]
33. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk. Vachon CM; Scott CG; Tamimi RM; Thompson DJ; Fasching PA; Stone J; Southey MC; Winham S; Lindström S; Lilyquist J; Giles GG; Milne RL; MacInnis RJ; Baglietto L; Li J; Czene K; Bolla MK; Wang Q; Dennis J; Haeberle L; Eriksson M; Kraft P; Luben R; Wareham N; Olson JE; Norman A; Polley EC; Maskarinec G; Le Marchand L; Haiman CA; Hopper JL; Couch FJ; Easton DF; Hall P; Chatterjee N; Garcia-Closas M Breast Cancer Res; 2019 May; 21(1):68. PubMed ID: 31118087 [TBL] [Abstract][Full Text] [Related]
34. Assessment of 'cancer-prone personality' characteristics in healthy study subjects and in patients with breast disease and breast cancer using the commitment questionnaire: a prospective case-control study in Finland. Eskelinen M; Ollonen P Anticancer Res; 2011 Nov; 31(11):4013-7. PubMed ID: 22110235 [TBL] [Abstract][Full Text] [Related]
35. Lower-category benign breast disease and the risk of invasive breast cancer. Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339 [TBL] [Abstract][Full Text] [Related]
36. Measurement of pessimism: hopelessness scale in healthy study subjects, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland. Eskelinen M; Ollonen P Anticancer Res; 2011 Nov; 31(11):4019-23. PubMed ID: 22110236 [TBL] [Abstract][Full Text] [Related]
37. Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low. Cao S; Zhu Z; Zhou J; Li W; Dong Y; Qian Y; Wei P; Wu M Breast Cancer Res Treat; 2021 Jun; 187(3):793-804. PubMed ID: 33599865 [TBL] [Abstract][Full Text] [Related]
38. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983 [TBL] [Abstract][Full Text] [Related]
39. Family history of breast cancer, age and benign breast disease. Webb PM; Byrne C; Schnitt SJ; Connolly JL; Jacobs T; Peiro G; Willett W; Colditz GA Int J Cancer; 2002 Jul; 100(3):375-8. PubMed ID: 12115556 [TBL] [Abstract][Full Text] [Related]
40. Somatic mutations in benign breast disease tissues and association with breast cancer risk. Winham SJ; Wang C; Heinzen EP; Bhagwate A; Liu Y; McDonough SJ; Stallings-Mann ML; Frost MH; Vierkant RA; Denison LA; Carter JM; Sherman ME; Radisky DC; Degnim AC; Cunningham JM BMC Med Genomics; 2021 Jul; 14(1):185. PubMed ID: 34261476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]